User profiles for Allison J McGeer
 | Allison McGeerProfessor, University of Toronto Verified email at sinaihealth.ca Cited by 60669 |
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
While the antibody response to SARS-CoV-2 has been extensively studied in blood,
relatively little is known about the antibody response in saliva and its relationship to systemic …
relatively little is known about the antibody response in saliva and its relationship to systemic …
[HTML][HTML] Identification of severe acute respiratory syndrome in Canada
…, M Petric, RC Brunham, AJ McGeer - … England Journal of …, 2003 - Mass Medical Soc
Background Severe acute respiratory syndrome (SARS) is a condition of unknown cause
that has recently been recognized in patients in Asia, North America, and Europe. This report …
that has recently been recognized in patients in Asia, North America, and Europe. This report …
[HTML][HTML] Acute myocardial infarction after laboratory-confirmed influenza infection
Background Acute myocardial infarction can be triggered by acute respiratory infections.
Previous studies have suggested an association between influenza and acute myocardial …
Previous studies have suggested an association between influenza and acute myocardial …
Seasonal influenza in adults and children—diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the …
Guidelines for the treatment of persons with influenza virus infection were prepared by an
Expert Panel of the Infectious Diseases Society of America. The evidence-based guidelines …
Expert Panel of the Infectious Diseases Society of America. The evidence-based guidelines …
Incorporating variations in the quality of individual randomized trials into meta-analysis
Meta-analysis is a method of synthesizing evidence from multiple sources. It has been
increasingly applied to combine results from randomized trials of therapeutic strategies. …
increasingly applied to combine results from randomized trials of therapeutic strategies. …
[HTML][HTML] Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission
Wildlife reservoirs of broad-host-range viruses have the potential to enable evolution of viral
variants that can emerge to infect humans. In North America, there is phylogenomic …
variants that can emerge to infect humans. In North America, there is phylogenomic …
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory …
It is not understood how immune inflammation influences the pathogenesis of severe acute
respiratory syndrome (SARS). One area of strong controversy is the role of interferon (IFN) …
respiratory syndrome (SARS). One area of strong controversy is the role of interferon (IFN) …
[HTML][HTML] A simple protein-based surrogate neutralization assay for SARS-CoV-2
Most of the patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
mount a humoral immune response to the virus within a few weeks of infection, but the …
mount a humoral immune response to the virus within a few weeks of infection, but the …
Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2
…, M Taylor, L Yip, XZ Zhong, AJ McGeer… - Clinical Infectious …, 2021 - academic.oup.com
We enrolled 91 consecutive inpatients with COVID-19 at 6 hospitals in Toronto, Canada,
and tested 1 nasopharyngeal swab/saliva sample pair from each patient using real-time RT-…
and tested 1 nasopharyngeal swab/saliva sample pair from each patient using real-time RT-…
[HTML][HTML] Isolation, sequence, infectivity, and replication kinetics of severe acute respiratory syndrome coronavirus 2
Since its emergence in Wuhan, China, in December 2019, severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has infected≈ 6 million persons worldwide. As SARS-CoV-2 …
coronavirus 2 (SARS-CoV-2) has infected≈ 6 million persons worldwide. As SARS-CoV-2 …